Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I know it’s only another glimmer but I was just musing the current dollar/sterling exchange rate which is now around 1.10 where it was around 1.24 at the time of administration & from memory I think we had 7.4 million dollars on deposit( or just under £6 million) at the time , but at current exchange rates it’s more like £6.8 million now which is a significant jump if it still remains on deposit of course, and not been paid out as yet. At £650 an hour for interpath it won’t do us any harm 4 sure . GLA
Morning Crl, good to hear from you and for the work you are doing in the background. So pleased you haven't given up, all to often you read on these BBs of people losing big time and just disappearing, shows real spirit to keep up the fight so fair play to you. I also hope as we head in to winter that you wife has let you back in the house.
Like many here I still cant believe this will end with nothing good considering what the data and research should be valued at.
Gla
crl123 I know you are working hard for the group. If there is any justice here something just might go for us. Thanks once more for your help.
Hi both of you. Not been here a while.
Interpath reaffirmed in recent RNS that they were still searching for a ‘ going concern’ . They did not have to do that as the RNS was not about Admin. Recent dates for scientific posters in RNS 2 weeks ago on 0518 also show that there are things moving . I personally think it is in order to increase value of 0518 for sale, as Merck are foolish to abandon its Keytruda efficacy. I am a cynic through and through as have been taken for a ride too many times for being naive or trusting, but I fully acknowledge increasing value of assets recently. Problem I have is that the vultures will still pick off the carrion at rock bottom regardless as Admin is simply interested in paying secured creditors and takong est. £4m themselves , angelic promises or not.
The last 3-4 months have been harder than lockdown for me , and I mix hope with profound cynicism as I know how corrupt and the market is and how greedy the Admin process is.
It’sall speculation until the Fat Lady sings. And she has lost a lot of weight in 3 1/2 months!
I hope you two are ok and faring better than I. Loss of £97k ( pretty much all I have) has knocked me and family for 6. But some of the 166 SAG members have equally horrific stories. 4D really has caused serious human carnage. Unforgiveable.
(Well…it does not compare to the horror inflicted by Vlad the Impaler in Ukraine, and the trauma of that will endure and endure. I was o Ukraine/Poland border at a martial arts champs in 2019. Russia can never defeat spirit ( as in France ‘39-45). I meet up with Ukraine team in 3 weeks in Wales at World Champs..I bet they will get an almighty cheer.) Sorry, distracted.
Thanks Michael for info.Email anytime.
Wishing you both the best.
Michael I have just re read your June comments which as always were well thought out and positive. Let's hope you are not far off the mark.
Michael wouldn't it be nice if we came back from the dead. Still cannot work out how we got in this situation. I thought when you are down people just take advantage and kick you a bit more if that is possible.
Seres Therapeutics market cap has climbed from a low of US$300M to > USD $850m in a few months! Seres is one of the leaders - if not the leader - in LBPs, the very same sub-sector of the Pharma/Biotech as 4D.
Shortly before 4D went into administration and as increasing signs of 4D incompetent management were starting to surface, I'd argued that a buyout or a merger with Seres (or a firm like it though there aren't that many of decent size in LBP) would be an excellent way to provide value for all stakeholders.
Seres might not have sufficient cash, but 4D investors could receive shares in the enlarged company.
First, I was a little encouraged by the fact that administrators had approached 50 companies in the sector. I can only think that Seres were on the top of the list. 4D's pipeline should be nicely complementary to the portfolio of Seres (or that of other competitors) given its unusual single-strain approach and the variety of illnesses targeted.
Every now and then, I'm checking the share price of Seres as a barometer for the popularity and extent of recovery of the LBP sub-sector. Almost every time I check the share price is significantly higher. That could mean that 4D assets are becoming more and more affordable from Seres's perspective and that the value of the 4d assets themselves must also be getting part of the benefit from an increase in affordability.
In any case, 4d's assets must have gained some significant value since June especially in the light of the recent RNS. However for that to be realised there has to have been some parallel expressions of interest.
Now, the basis of a (possible) deal be it:
- refinancing of debt with 4D coming back into life from coma or
- an M&A deal
- or a partial sale of assets to pay off debt and with 4D coming back
should be getting stronger and the chances that the shareholders will find it somewhat satisfactory must be getting better.
If the company was to come back I'd trust that Duncan Peyton and the CFO would have no role in a re-emerged 4D or, in the case of Duncan, certainly not the same role as before.
You've got some capital gains somewhere ?! Good for you, nothing I have is in the blue at the moment !
We are getting more updates now since the company went into administration than we did when Duncan was fully active. You couldn't make it up. LOL
The shares were temporarily suspended from 24/06/2022 12:30pm that's over 20 weeks ago or 4 months, not sure how long administrators take but you would think by now we there would be some kind of update.
Would like to see this closed off now, I can use the loss once its confirmed against my capital gains.
Fingers crossed for the benefit of all cancer suffers and shareholders
with 4d nearest rival Seres valued at $700m, surely we can manage a relist / refinance, at say $300m.
:) lols
way over optimistic i know but you get my point,
An IPO in the states for the data we already have i bet you wouldnt get a sniff for less than $500m.
Therein is the opportunity
In regard to the latest RNS this afternoon, it appears to me they are not acting like they are dead in the water and have thrown in the towel just yet.
Presenting Posters next month is a positive surely ?
muldoon, is it to be believed OF came in with a significant funding without having done due diligence,( knowing the value of the research, particularly with Merck onboard). Then within 1 year of the loan agreement pulled the plug The plug was pulled,imo, when OF discovered the BOD were in contravention of the loan agreement and were not impressed with the way the company was being managed.
OF may just want their money back, however the time Adminstrators are taking could be allowing negotiations to take place with the funder. Merck are no mugs, and neither is OF
I’m like most on here not holding out a great deal of faith in truth but I’d like to think that today gives us a glimmer potentially .
That said the wording may be exactly as Mig stated earlier & yes I accept fully at £650 an hour the administrators are coining it in .
Looking at what’s available here with 4d I still can’t believe with the dollar strength right now that it surely offers the likes of Merck & others a golden opportunity to pick this up for a fraction of what its truly worth , or was .
Look we are where we are , that’s the bottom line and whilst hope is no strategy that final paragraph offers me some faint hope I guess . GLA
Yes I would have thought they will need to find some kind of refinancing deal to pay off OF and operating revenue for the forseeable future (is it 6months?).
They either need to sell something or find a new loan from somewhere.
I also guess the board will need to be replaced to gain some stability and trust in the company - if it can be saved.
Surely OF will be paid off and will then have nothing more to do with the company. Why and in what sense would OF "want almost full control of the equity" ?
the intention will be to pay OF off then tell em to FO
imvho
Death by a 1000 cuts. Administrators as always, are doing very nicely at £650/hr. IF 4D does get relisted, the lenders OF will want almost full control of the equity.
I think my investment is dead here. The administrators will obviously be looking at ways to relist the company. It's their job really. Imo they just haven't completed the whole job so can't announce and the line about working ways to relist the company is just another way of saying we are still working on their administration.
It’s looking good
My hope is alive again
Let’s hope and pray it works out
But we will need to wait a little longer now
It does look from the RNS that they are looking at returning the company to trading, rather than selling.
Suspect they are looking therefore at some sort of financing deal, or maybe selling an asset.
Wow, the RNS actually mentions the possibility returning the company from suspension. Seeing that in an RNS is cautiously very positive for me.
Who knows
It’s gone very quiet regards #dddd and on this board as well.
I’ve written it off personally so anything we may get back is a bonus.
Just shows that as the ‘funders’ we haven’t got that much say in the goings on of the company, nor when its in administration.
Ah well…….
0.030 USD
+0.011 (57.37%)today
26 Sept, 16:00 GMT-4 • Disclaimer
Any news or anything?